Expressive Writing for COVID-19 Resilience for Parents
1 other identifier
interventional
11
1 country
1
Brief Summary
The purpose of this study is to determine the impact of a 4-week, virtually-delivered expressive writing intervention on resilience in a cohort of parents and caregivers currently navigating the COVID-19 pandemic during spring \& summer of 2020.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2020
CompletedFirst Submitted
Initial submission to the registry
October 12, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedNovember 24, 2021
November 1, 2021
2 months
October 12, 2020
November 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Resilience
Connor-Davidson Resilience Scale (CD-RISC)
3 months
Secondary Outcomes (3)
Perceived stress
3 months
Depression symptoms
3 months
Parental stress
3 months
Study Arms (1)
Expressive writing
EXPERIMENTALThe 4-week study intervention will invite participants through a progression of expressive writing exercises designed to support emotional expression and enhance personal resilience. Weekly instruction writing sessions will be conducted via Zoom. The sessions will not be recorded, but participants who cannot attend the sessions live (or prefer not to, for any reason) will receive each week's instructions and prompts via email. The progression of writing exercises flows as follows: * Week 1: Writing to expressive difficult emotions * Week 2: Writing to cultivate compassion \& forgiveness * Week 3: Writing to nurture positive emotions * Week 4: Writing to invite insight, perspective, \& growth
Interventions
The 4-week study intervention will invite participants through a progression of expressive writing exercises designed to support emotional expression and enhance personal resilience. Weekly instruction writing sessions will be conducted via Zoom. The sessions will not be recorded, but participants who cannot attend the sessions live (or prefer not to, for any reason) will receive each week's instructions and prompts via email. The progression of writing exercises flows as follows: * Week 1: Writing to expressive difficult emotions * Week 2: Writing to cultivate compassion \& forgiveness * Week 3: Writing to nurture positive emotions * Week 4: Writing to invite insight, perspective, \& growth
Eligibility Criteria
You may qualify if:
- In order to have up to 40 evaluable subjects, we plan to consent up to 45 individuals. Potential subjects will be considered eligible if they are parents or primary caregivers of children aged 0-18 who have been home with them during the COVID-19 experience. Other eligibility criteria include:
- Able to speak, read, write, and understand English
- Cognitively able to provide consent
- Ability to participate in a 4-week intervention delivered via Zoom and email
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Integrative Medicine
Durham, North Carolina, 27705, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Oliver Glass, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2020
First Posted
October 19, 2020
Study Start
May 27, 2020
Primary Completion
August 2, 2020
Study Completion
August 2, 2020
Last Updated
November 24, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share